Longer times from symptom onset to randomization equaled a smaller—or perhaps no—advantage for Impella vs standard care.
Just one in three North American patients admitted to the cardiac intensive care unit (CICU) for STEMI complicated by cardiogenic shock (STEMI-CS) would meet the high bar set for entry into the DanGer ...
Ashley Yeager always loved to swim, but had to adjust after being diagnosed with a serious heart rhythm condition. (Courtesy of Allison Martin-Attix) This story is from The Pulse, a weekly health and ...
FDA Also Approves and Closes RECOVER III Post-Approval Study DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (Nasdaq: ABMD) announces two approvals from the U.S. Food and Drug Administration (FDA) related to ...
The American Heart Association has created new registry will help researchers, clinicians and regulators to better understand the clinical symptoms of shock types, treatment patterns and outcomes. The ...
PARIS--(BUSINESS WIRE)--Inotrem, an advanced clinical stage biotech company specializing in immunotherapies for acute and chronic inflammatory syndromes, disclosed for the first time today at the ...
Please provide your email address to receive an email when new articles are posted on . “Even though septic shock is a well-recognized deadly condition, our study, one of the first to use the Sepsis-3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback